about
Relative bioavailability of chlorothiazide from mucoadhesive compacts in pigs.Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test.The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.Strategies to improve oral drug bioavailability.Gastroretentive drug delivery systems.pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release.A critical review of gastric retentive controlled drug delivery.Evaluation of polyethylene oxide compacts as gastroretentive delivery systems.Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.Drug release kinetics and physicochemical characteristics of floating drug delivery systems.Advances in gastro retentive drug-delivery systems.Gastroretentive microparticles for drug delivery applications.Industrial perspective of gastroretentive drug delivery systems: physicochemical, biopharmaceutical, technological and regulatory consideration.Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?Gastroretentive drug delivery systems for the treatment of Helicobacter pylori.Innovative Methods and Applications in Mucoadhesion Research.Nonclinical Safety Assessment of SYN-004: An Oral β-lactamase for the Protection of the Gut Microbiome From Disruption by Biliary-Excreted, Intravenously Administered Antibiotics.Triggerable tough hydrogels for gastric resident dosage forms.Formulation and evaluation of floating matrix tablet of stavudine.Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine.Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection.Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systemsGastroretentive hydrodynamically balanced systems of ofloxacin: In vitro evaluation.Optimization of a dual mechanism gastrofloatable and gastroadhesive delivery system for narrow absorption window drugs.Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.Development and evaluation of in situ gel of pregabalin.Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets.Natural gum as mucoadhesive controlled release carriers: evaluation of cefpodoxime proxetil by D-optimal design technique.Optimization and characterization of gastroretentive floating drug delivery system using Box-Behnken design.In vitro and in vivo evaluation of ranitidine hydrochloride ethyl cellulose floating microparticles.A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.Study of controlled-release floating tablets of dipyridamole using the dry-coated method.Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide.Design and development of novel lipid based gastroretentive delivery system: response surface analysis, in-vivo imaging and pharmacokinetic study.
P2860
Q33563572-68B0A607-DB4F-4894-9290-AB0DC14991A9Q33566190-3E3C0874-A11E-4A09-8C66-312C76B0A48BQ36088451-B8DDE848-6875-4362-B5FC-23718D48010BQ36316751-18CDEE6B-24F5-45C9-A962-E0708E7F10DAQ36409044-F71F4072-68CF-4B68-986F-A4B6B8AB2C8AQ36422796-2FF5869F-36CA-424A-8D13-60D4F7B565EAQ36813052-5E8738ED-751F-40D5-9EEC-BD6E363E9A85Q37146161-B35B98E1-3D2F-489D-A40A-2D1A149DDE60Q37436438-4792D9D8-0C78-494F-AE0F-458EC7E82151Q37801383-57F767C0-D3F8-437F-ABAD-40C68AAB70C8Q37867128-C39C475F-1874-4191-BB2A-BB41CBC3C1E5Q37889295-F0947A70-D75E-4332-A631-5DCC09983706Q37897216-8A28B594-3D92-40F9-89B2-F8C9AEDDB376Q38003472-4B7C109F-76B8-4579-955D-801DCC38F891Q38229749-89AA1BFE-40E2-4BB6-95A8-F67855D7C04EQ38234873-A4C8CD1C-717D-4AD6-BF7F-1A3B379C8673Q39221315-2846F069-6C7E-4E9E-AD25-198C7E21FB1FQ40175672-0C5C354C-D324-47DC-B3E8-D56C766D6EEDQ41125798-DCC4EFE4-A49F-4208-8723-CB88E0C062E0Q41674972-21519AD5-B292-4550-BA64-3E0A4D563FC5Q41848180-178B4CF3-C740-44A3-B06D-6379A1BFCA9DQ41871069-7AE62DD9-F60A-42BA-8223-316EA93ED5A8Q41989264-1AE5DF00-2F01-4609-A9BC-ED0CD36F449CQ42016419-D3F799F5-ABAC-4981-99D6-76B3F0A8B791Q42090300-9EA2E2B6-F539-45C9-8E62-4B7806733D56Q42588782-435DAC45-EA6B-4453-9412-5AC8C7F41949Q43130344-E92FDBD7-B182-4BC0-8E61-3ED681CDDB0EQ43136193-141BCAFC-5058-4422-ACD8-54FD0CB7FF24Q43152668-1A59C730-4041-498D-AC86-B8791DD5CDEEQ44341240-ECE9D60B-5E85-4AA5-91CD-32B2A586C60CQ44456614-B7F6D762-E4DB-437E-ABF8-4E808AEED50DQ44503466-12910D44-5EDC-4EAE-BEB2-604AABCADD27Q46674353-D1CF8D76-EACD-4B78-A106-5A29F1428441Q47909177-5F231808-08F5-4B5E-8457-EDA26C74C9E2Q48237580-33F88B57-2544-4B8D-9B5E-F718A5C09B06Q54422355-A1C54876-DCD3-4472-BF66-2DF6B848991D
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expandable gastroretentive dosage forms.
@ast
Expandable gastroretentive dosage forms.
@en
type
label
Expandable gastroretentive dosage forms.
@ast
Expandable gastroretentive dosage forms.
@en
prefLabel
Expandable gastroretentive dosage forms.
@ast
Expandable gastroretentive dosage forms.
@en
P2093
P1476
Expandable gastroretentive dosage forms.
@en
P2093
Amnon Hoffman
Eytan A Klausner
Michael Friedman
P304
P356
10.1016/S0168-3659(03)00203-7
P407
P577
2003-06-01T00:00:00Z